Intravitreal bevacizumab in the management of breast cancer iris metastasis
Conclusion: Intravitreal anti–vascular endothelial growth factor therapy for breast cancer metastatic to the iris with secondary neovascular glaucoma provided good local control for a limited follow-up period, because the patient died because of systemic complications of her disease.
Source: Retinal Cases and Brief Reports - Category: Opthalmology Tags: Case Report Source Type: research
More News: Avastin | Breast Cancer | Cancer | Cancer & Oncology | Eye Cancers | Eyes | Glaucoma | Pain | Pain Management | Ultrasound